IP Verse

Method For Generating T-Cells Compatible For Allogenic Transplantation - EP4368705

The patent EP4368705 was granted to Cellectis on Jan 1, 2025. The application was originally filed on Mar 11, 2015 under application number EP24153261A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4368705

CELLECTIS
Application Number
EP24153261A
Filing Date
Mar 11, 2015
Status
Granted And Under Opposition
Nov 29, 2024
Grant Date
Jan 1, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

CARPMAELS & RANSFORD SPECIALITIESOct 1, 2025ADMISSIBLE
MARGARET DIXONSep 30, 2025ADMISSIBLE
CENTURY THERAPEUTICSSep 29, 2025ADMISSIBLE
MURGITROYDSep 29, 2025ADMISSIBLE
CENTURY THERAPEUTICSJan 2, 2025 -

Patent Citations (53) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2013US58005-
DESCRIPTIONFR901228
DESCRIPTIONUS2002086356
DESCRIPTIONUS2002162126
DESCRIPTIONUS2003108923
DESCRIPTIONUS2006121005
DESCRIPTIONUS4474893
DESCRIPTIONUS4683195
DESCRIPTIONUS5093246
DESCRIPTIONUS5858358
DESCRIPTIONUS5883223
DESCRIPTIONUS6010613
DESCRIPTIONUS6352694
DESCRIPTIONUS6506559
DESCRIPTIONUS6534055
DESCRIPTIONUS6692964
DESCRIPTIONUS6797514
DESCRIPTIONUS6867041
DESCRIPTIONUS6887466
DESCRIPTIONUS6905680
DESCRIPTIONUS6905681
DESCRIPTIONUS6905874
DESCRIPTIONUS7067318
DESCRIPTIONUS7144575
DESCRIPTIONUS7172869
DESCRIPTIONUS7175843
DESCRIPTIONUS7232566
DESCRIPTIONWO0044895
DESCRIPTIONWO0136646
DESCRIPTIONWO02055692
DESCRIPTIONWO02055693
DESCRIPTIONWO0244321
DESCRIPTIONWO03006477
DESCRIPTIONWO2004083379
DESCRIPTIONWO2006097854
DESCRIPTIONWO2012012667
DESCRIPTIONWO2012138927
DESCRIPTIONWO2013126712
DESCRIPTIONWO2013176915
DESCRIPTIONWO2013176916
DESCRIPTIONWO2014018601
DESCRIPTIONWO9011364
SEARCHUS2006222633
SEARCHWO2005097160
SEARCHWO2008102274
SEARCHWO2012145384
SEARCHWO2013049459
SEARCHWO2013074916
SEARCHWO2013158292
SEARCHWO2013176915
SEARCHWO2014165707
SEARCHWO9302188
SEARCHWO9517911

Non-Patent Literature (NPL) Citations (56) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BIERER et al., Citrr. Opin. mm n., vol. 5, pages 763 - 773-
DESCRIPTION- BOCH, J.H. SCHOLZE et al., "Breaking the code of DNA binding specificity of TAL-type III effectors", Science, (20090000), vol. 326, no. 5959, pages 1509 - 12-
DESCRIPTION- CAMBIER, J. C., "Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM", J Immunol, (19950000), vol. 155, no. 7, pages 3281 - 5-
DESCRIPTION- FEHLING et al., Science, (19990000), vol. 265, pages 1234 - 1237-
DESCRIPTION- GARBI et al., Nat. Immunol., (20000000), vol. 1, pages 234 - 238-
DESCRIPTION- "GenBank", Database accession no. NC_000015-
DESCRIPTION- GRANDEA et al., Immunity, (20000000), vol. 13, pages 213 - 222-
DESCRIPTION- Handbook Of Experimental Immunology, Cold Spring Harbor Laboratory Press, (19860000), vol. 1-4-
DESCRIPTION- HENDERSON et al., Immun., (19910000), vol. 73, pages 316 - 321-
DESCRIPTION- KIM, Y, PLOS Pathogens, (20080000), vol. 4, page e1000123-
DESCRIPTION- KRANZ et al., Proc. Natl. Acad. Sci. USA, (19810000), vol. 78, page 5807-
DESCRIPTION- LJUNGGREN HG et al., Immunl Today, (19900000), vol. 11, pages 237 - 244-
DESCRIPTION- LJUNGGREN HG et al., Immunl Today., (19900000), vol. 11, pages 237 - 244-
DESCRIPTION- MACH B.STEIMLE VREITH W, "MHC class II-deficient combined immunodeficiency: a disease of gene regulation", Immunol. Rev., (19940000), vol. 138, no. 1, pages 207 - 21, XP055738777-
DESCRIPTION- MA, J. L.E. M. KIM et al., "Yeast Mre11 and Rad1 proteins define a Ku-independent mechanism to repair double-strand breaks lacking overlapping end sequences", Mol Cell Biol, (20030000), vol. 23, no. 23, pages 8820 - 8-
DESCRIPTION- MOSCOU, M. J.A. J. BOGDANOVE, "A simple cipher governs DNA recognition by TAL effectors", Science, (20090000), vol. 326, no. 5959, page 1501, XP002599998-
DESCRIPTION- "NCBI", Database accession no. NG_009628.1-
DESCRIPTION- RAULET DH, Nature Reviews Immunology, (20030000), vol. 3, no. 10, pages 781 - 79-
DESCRIPTION- SALIH HRANTROPIUS HGIESEKE FLUTZ SZKANZ L et al., "Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia", Blood, (20030000), vol. 102, pages 1389 - 1396, XP002360664-
DESCRIPTION- SALIH HR et al., Blood, (20030815), vol. 102, no. 4, pages 1389 - 96-
DESCRIPTION- SALIH HR et al., Hum Immunol., (20060300), vol. 67, no. 3, pages 188 - 95-
DESCRIPTION- SALIH HR et al., J Immunol., (20020000), vol. 169, no. 8, pages 4098 - 102-
DESCRIPTION- WALDHAUER ISTEINLE A, "Proteolytic release of soluble UL16-binding protein 2 from tumor cells", Cancer Res, (20030000), vol. 66, no. 5, pages 2520 - 2526-
DESCRIPTION- WELTE SA et al., Eur J Immunol, (20030000), vol. 33, no. 1, pages 194 - 203-
DESCRIPTION- WILKINSON G. et al., J Clin Virol., (20100000), vol. 41, no. 3, pages 206 - 212-
DESCRIPTION- CARTER L et al., "PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2", Eur. J. Immunol., (20020000), vol. 32, no. 3, doi:10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9, pages 634 - 43, XP071220449
DESCRIPTION- WELTE, S.A.SINZGER, C.LUTZ, S.Z.SINGH-JASUJA, H.SAMPAIO, K.L.EKNIGK, U.RAMMENSEE, H.G.STEINLE, A., "Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein", Eur. J. Immunol., (20030000), vol. 33, doi:10.1002/immu.200390022, pages 194 - 203, XP055248300
DESCRIPTION- LIU L. et al., "Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes", Cell, (19910000), vol. 66, no. 4, doi:10.1016/0092-8674(91)90124-H, pages 807 - 815, XP027461712
DESCRIPTION- BIERER B.E. et al., "Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology", Curr Opin Immunol, (19930000), vol. 5, no. 5, doi:10.1016/0952-7915(93)90135-F, pages 763 - 73, XP023942528
DESCRIPTION- PARK, T. S.S. A. ROSENBERG et al., "Treating cancer with genetically engineered T cells", Trends Biotechnol, (20110000), vol. 29, no. 11, doi:10.1016/j.tibtech.2011.04.009, pages 550 - 7, XP028318600
DESCRIPTION- BETTS, M. R.J. M. BRENCHLEY et al., "Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation", J Immunol Methods, (20030000), vol. 281, no. 1-2, doi:10.1016/S0022-1759(03)00265-5, pages 65 - 78, XP004468180
DESCRIPTION- CRITCHLOW, S. E.S. P. JACKSON, "DNA end-joining: from yeast to man", Trends Biochem Sci, (19980000), vol. 23, no. 10, doi:10.1016/S0968-0004(98)01284-5, pages 394 - 8, XP004146845
DESCRIPTION- STODDARD, B. L, "Homing endonuclease structure and function", Q Rev Biophys, (20050000), vol. 38, no. 1, doi:10.1017/S0033583505004063, pages 49 - 95, XP008065807
DESCRIPTION- HASELOFFGERLACH, "Simple RNA enzymes with new and highly specific endoribonuclease activities", Nature, (19880000), vol. 334, doi:10.1038/334585a0, pages 585 - 591, XP002029776
DESCRIPTION- BIX M. et al., "Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice", Nature, (19910000), vol. 349, no. 6307, doi:10.1038/349329a0, pages 329 - 31, XP002389150
DESCRIPTION- DELTCHEVA, E.K. CHYLINSKI et al., "CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III", Nature, (20110000), vol. 471, no. 7340, doi:10.1038/nature09886, pages 602 - 7, XP055619637
DESCRIPTION- URNOV F.D. et al., "Genome editing with engineered zinc finger nucleases", Nature reviews Genetics, (20100000), vol. 185, doi:10.1038/nrg2842, pages 636 - 646, XP055198280
DESCRIPTION- GASIUNAS, G. et al., "Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria", Proc Natl Acad Sci USA, (20120000), vol. 109, no. 39, doi:10.1073/pnas.1208507109, pages 2579 - 86, XP055569955
DESCRIPTION- JINEK, M.K. CHYLINSKI et al., "A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity", Science, (20120000), vol. 337, no. 6096, doi:10.1126/science.1225829, pages 816 - 21, XP055229606
DESCRIPTION- CONG, L.F. A. RAN et al., "Multiplex genome engineering using CRISPR/Cas systems", Science, (20130000), vol. 339, no. 6121, doi:10.1126/science.1231143, pages 819 - 23, XP055400719
DESCRIPTION- MALI, P.L. YANG et al., "RNA-guided human genome engineering via Cas9", Science, (20130000), vol. 339, no. 6121, doi:10.1126/science.1232033, pages 823 - 6, XP055469277
DESCRIPTION- ASHWELL, J. D.R. D. KLUSNER, "Genetic and mutational analysis of the T-cell antigen receptor", Annu Rev Immunol, (19900000), vol. 8, doi:10.1146/annurev.iy.08.040190.001035, pages 139 - 67, XP008028181
DESCRIPTION- JENA, B.G. DOTTI et al., "Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor", Blood, (20100000), vol. 116, no. 7, doi:10.1182/blood-2010-01-043737, pages 1035 - 44, XP055021403
SEARCH- Glas Rickard ET AL, "Major histocompatibility complex class I-specific and -restricted killing of f32-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes", Proc. Natl. Acad. Sci. USA, (19921201), pages 11381 - 11385, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC50554/pdf/pnas01097-0284.pdf, (20230421), XP093041096 [A] 1-15 * the whole document *-
SEARCH- HOLLING T M ET AL, "Epigenetic silencing of MHC2TA transcription in cancer", BIOCHEMICAL PHARMACOLOGY, ELSEVIER, US, vol. 72, no. 11, ISSN 0006-2952, (20061130), pages 1570 - 1576, (20061130), XP027905310 [A] 1-15 * the whole document *-
SEARCH- GAJ THOMAS ET AL, "ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, (20130509), vol. 31, no. 7, doi:10.1016/J.TIBTECH.2013.04.004, ISSN 0167-7799, pages 397 - 405, XP028571313 [A] 1-15 * the whole document *
SEARCH- LAURA RIOLOBOS ET AL, "HLA Engineering of Human Pluripotent Stem Cells", MOLECULAR THERAPY, (20130430), vol. 21, no. 6, doi:10.1038/mt.2013.59, ISSN 1525-0016, pages 1232 - 1241, XP055145726 [A] 1-15 * the whole document * * page 1237, column r *
SEARCH- MARIA THEMELI ET AL, "Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy", NATURE BIOTECHNOLOGY, New York, (20130811), vol. 31, no. 10, doi:10.1038/nbt.2678, ISSN 1087-0156, pages 928 - 933, XP055485171 [A] 1-15 * the whole document *
SEARCH- P. HOGLUND ET AL, "Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (19911115), vol. 88, no. 22, doi:10.1073/pnas.88.22.10332, ISSN 0027-8424, pages 10332 - 10336, XP055145720 [A] 1-15 * the whole document *
SEARCH- DAMMEYER P ET AL, "Vaccination with beta(2)-Microglobulin-Deficient Dendritic Cells Protects Against Growth of beta(2)-Microglobulin-Deficient Tumours", SCANDINAVIAN JOURNAL OF IMMUNOLOGY, BLACKWELL SCIENCE PUBL., OXFORD, GB, vol. 70, no. 1, doi:10.1111/J.1365-3083.2009.02270.X, ISSN 0300-9475, (20090425), pages 44 - 52, (20090425), XP002544734 [A] 1-15 * the whole document * * page 45, column l *
SEARCH- CONSTANÇA FIGUEIREDO ET AL, "Regulating MHC expression for cellular therapeutics", TRANSFUSION, US, (20070101), vol. 47, no. 1, doi:10.1111/j.1537-2995.2007.01059.x, ISSN 0041-1132, pages 18 - 27, XP055738565 [A] 1-15 * the whole document *
SEARCH- AGNIESZKA WIECZOREK ET AL, "Genetically Modified T Cells for the Treatment of Malignant Disease", TRANSFUSION MEDICINE AND HEMOTHERAPY, (20131129), vol. 40, no. 6, doi:10.1159/000357163, ISSN 1660-3796, pages 388 - 402, XP055145975 [A] 1-15 * the whole document *
SEARCH- HIROKI TORIKAI ET AL, "Toward eliminating HLA class I expression to generate universal cells from allogeneic donors", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, (20130605), vol. 122, no. 8, doi:10.1182/BLOOD-2013-03-478255, ISSN 0006-4971, pages 1341 - 1349, XP002719612 [A] 1-15 * the whole document *
SEARCH- MELISA A. SOLAND ET AL, "Modulation of Human Mesenchymal Stem Cell Immunogenicity through Forced Expression of Human Cytomegalovirus US Proteins", PLOS ONE, (20120530), vol. 7, no. 5, doi:10.1371/journal.pone.0036163, page e36163, XP055187588 [A] 1-15 * the whole document *
SEARCH- V. TRICHET ET AL, "Complex Interplay of Activating and Inhibitory Signals Received by V 9V 2 T Cells Revealed by Target Cell 2-Microglobulin Knockdown", THE JOURNAL OF IMMUNOLOGY, (20061018), vol. 177, no. 9, doi:10.4049/jimmunol.177.9.6129, ISSN 0022-1767, pages 6129 - 6136, XP055145651 [A] 1-15 * the whole document *
SEARCH- Y. MATSUNAGA ET AL, "Activation of Antigen-Specific Cytotoxic T Lymphocytes by 2-Microglobulin or TAP1 Gene Disruption and the Introduction of Recipient-Matched MHC Class I Gene in Allogeneic Embryonic Stem Cell-Derived Dendritic Cells", THE JOURNAL OF IMMUNOLOGY, (20081020), vol. 181, no. 9, doi:10.4049/jimmunol.181.9.6635, ISSN 0022-1767, pages 6635 - 6643, XP055145645 [A] 1-15 * the whole document * * abstract *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents